Paper984580
Site of action of inhaled 6 per cent carbon dioxide in the lungs of asthmatic subjects before and after exercise.
Fisher HK and 1 other. Am Rev Respir Dis, 1976. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Site of action of inhaled 6 per cent carbon dioxide in the lungs of asthmatic subjects before and after exercise. Papers, record 984580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/984580
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Site of action of inhaled 6 per cent carbon dioxide in the lungs of asthmatic subjects before and after exercise.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asthma | Major topic |
| Carbon Dioxide | Major topic |
| Lung | Major topic |
| Physical Exertion | Major topic |
| Adolescent | |
| Adult | |
| Airway Obstruction | |
| Airway Resistance | |
| Atropine | |
| Blood Gas Analysis | |
| Bronchial Spasm | |
| Humans | |
| Lung Volume Measurements | |
| Muscle Relaxation | |
| Muscle, Smooth | |
| Pulmonary Ventilation | |
| Respiratory System |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40668657 | Sensing molecular carbon dioxide: a translational focus for respiratory disease. | Physiol Rev | 2025 | https://conductscience.org/library/papers/40668657 | PubMed |
| 37817178 | Carbon dioxide and MAPK signalling: towards therapy for inflammation. | Cell Commun Signal | 2023 | https://conductscience.org/library/papers/37817178 | PubMed |
| 33628424 | Elevated CO2 modulates airway contractility. | Interface Focus | 2021 | https://conductscience.org/library/papers/33628424 | PubMed |
| 33027886 | Hypercapnia: An Aggravating Factor in Asthma. | J Clin Med | 2020 | https://conductscience.org/library/papers/33027886 | PubMed |
| 30185650 | Hypercapnia increases airway smooth muscle contractility via caspase-7-mediated miR-133a-RhoA signaling. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/30185650 | PubMed |
| 29914544 | A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma. | Trials | 2018 | https://conductscience.org/library/papers/29914544 | PubMed |
| 27739872 | The Clinical Significance of Collateral Ventilation. | Ann Am Thorac Soc | 2016 | https://conductscience.org/library/papers/27739872 | PubMed |
| 27464582 | A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers. | Trials | 2016 | https://conductscience.org/library/papers/27464582 | PubMed |
| 25355286 | Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma. | Respir Res | 2014 | https://conductscience.org/library/papers/25355286 | PubMed |
| 556258 | Influence of antigen challenge on density dependence of maximal expiratory flow and nitrogen washout curves in extrinsic bronchial asthma. | Lung | 1979 | https://conductscience.org/library/papers/556258 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/984580
GET https://conductscience.org/api/papers/v1/984580/authors